bell
The current prices are delayed by 15 mins, login to check live prices.
Parmax Pharma Ltd share price logo

Parmax Pharma Ltd

(540359)

₹42.524.98%

as on 04:01PM, 11 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Parmax Pharma Ltd Performance

  • Day's High

    ₹42.52
    ₹46.98
  • 52 Week's Low

    52 Week's High

    ₹24.18
    ₹54
1 Month Return-8.67 %
3 Month Return+ 15.19 %
1 Year Return+ 45.1 %
Previous Close₹44.75
Open₹44.75
Volume1,595.00
Upper Circuit-
Lower Circuit-
Market Cap₹16.74Cr

Parmax Pharma Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹16.74 Cr
P/B Ratio178
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE0

Parmax Pharma Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹16.74 Cr27.35%0.99NANA
NA₹1,150.87 Cr-0.07%0.56₹41 Cr₹338 Cr
NA₹7,087.55 Cr6.82%0.79-₹388 Cr₹75 Cr
NA₹9,303.54 Cr7.13%0.53NANA
NA₹29.20 Cr144.03%0.50NANA

About Parmax Pharma Ltd

Parmax Pharma PPL is a public limited company which was incorporated in November 1994 and promoted by Jayantilal S Dhol Purushottam J Bhalodi and Prabhudas D Hansalpara. It has set up a plant in Hadamtala Gujarat and has an installed capacity of 96 tonnes per annum for the production of bulk drugs such as amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid. Its Antibiotic project has been completely implemented since 31st May 1997 and its non Antibiotic products project is currently in its final stages of implementation.

Share Price: ₹42.52 per share as on 11 Dec, 2024 04:01 PM
Market Capitalisation: ₹16.74Cr as of today
OrganisationParmax Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Parmax Pharma Ltd

  • Parmax Pharma Reports Strong Sales Growth - 25 Nov, 2024

    Parmax Pharma's standalone net sales for September 2024 reached Rs 9.28 crore, a 128.05% increase year-on-year. Despite a quarterly net loss of Rs 0.22 crore, the company shows significant growth in EBITDA and strong stock performance, with 53.17% returns over the last six months.

Insights on Parmax Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 69.20% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.6% return, outperforming this stock by 16.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 137.3% return, outperforming this stock by 152.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 30.80% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Parmax Pharma stock has moved down by -9.1%

Parmax Pharma Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹22.73Cr (-)₹17.97Cr (↓20.94%)₹17.60Cr (↓2.06%)₹15.33Cr (↓12.90%)
Total Liabilities₹16.91Cr (-)₹12.01Cr (↓28.98%)₹11.75Cr (↓2.16%)₹15.26Cr (↑29.87%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹2.82Cr (-)₹3.53Cr (↑25.18%)₹0.75Cr (↓78.75%)₹0.33Cr (↓56.00%)-₹0.19Cr (↓157.58%)
0

Parmax Pharma Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
30.8%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
69.2%
0.00
Others
0%
0.00

Parmax Pharma Ltd Key Indicators

Details2020202120222023
Return On Equity %8.8813.792.38-1.69

Parmax Pharma Ltd Earnings and Dividends

  • Parmax Pharma Ltd Earnings Results

    Parmax Pharma Ltd’s net profit jumped 83.94% since last year same period to ₹0.22Cr in the Q2 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -2300% fall in its net profits since last 3-months.

    Read More about Earnings Results

Parmax Pharma Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Parmax Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Parmax Pharma Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Parmax Pharma Ltd shares.

Parmax Pharma Ltd (540359) share price today is ₹42.52

Parmax Pharma Ltd is not listed on NSE

Parmax Pharma Ltd is listed on BSE

  • Today’s highest price of Parmax Pharma Ltd is ₹46.98.
  • Today’s lowest price of Parmax Pharma Ltd is ₹42.52.

Today’s traded volume of Parmax Pharma Ltd(540359) is 1,595.00.

Today’s market capitalisation of Parmax Pharma Ltd(540359) is ₹16.74Cr.

Parmax Pharma Ltd(540359Price
52 Week High
₹54
52 Week Low
₹24.18

Parmax Pharma Ltd(540359) share price is ₹42.52. It is down -21.26% from its 52 Week High price of ₹54

Parmax Pharma Ltd(540359) share price is ₹42.52. It is up 75.85% from its 52 Week Low price of ₹24.18

Parmax Pharma Ltd(540359Returns
1 Day Returns
-2.23%
1 Month Returns
-8.67%
3 Month Returns
15.19%
1 Year Returns
45.1%